Immunological distinctions between nonalcoholic steatohepatitis and hepatocellular carcinoma.
Ontology highlight
ABSTRACT: Nonalcoholic fatty liver disease (NAFLD), the most common cause of chronic liver disease, ranges from simple hepatic steatosis to nonalcoholic steatohepatitis (NASH), which is a more aggressive form characterized by hepatocyte injury, inflammation, and fibrosis. Increasing evidence suggests that NASH is a risk factor for hepatocellular carcinoma (HCC), which is the fifth most common cancer worldwide and the second most common cause of cancer-related death. Recent studies support a strong mechanistic link between the NASH microenvironment and HCC development. The liver has a large capacity to remove circulating pathogens and gut-derived microbial compounds. Thus, the liver is a central player in immunoregulation. Altered immune responses are tightly associated with the development of NASH a
SUBMITTER: Koo SY
PROVIDER: S-EPMC8080649 | biostudies-literature | 2020 Aug
REPOSITORIES: biostudies-literature
ACCESS DATA